Join to View Full Profile
3181 SW Sam Jackson Park Rd# OregonPortland, OR 97239
Phone+1 503-494-7772
Fax+1 503-494-9059
Dr. Nutt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Neurology, 1973 - 1976
Oregon Health & Science University (OHSU Health)Internship, Internal Medicine, 1970 - 1971
Baylor College of MedicineClass of 1970
Certifications & Licensure
OR State Medical License 1979 - 2025
WA State Medical License Active through 2013
TX State Medical License 1970 - 1991
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2013
Clinical Trials
- Methylphenidate and Parkinson's Disease Start of enrollment: 2004 Jul 01
- Low Dose Apomorphine and Parkinsonism Start of enrollment: 2005 Oct 01
- High and Low Dose Treatment of Carbidopa in Parkinson's Disease Start of enrollment: 2008 Aug 01
- Join now to see all
Publications & Presentations
PubMed
- 2 citationsStride width and postural stability in frontal gait disorders and Parkinson's disease.Carolin Curtze, Vrutangkumar V Shah, Alexa M Stefanko, Marian L Dale, John G Nutt
Journal of Neurology. 2024-07-01 - 9 citationsDigital measures of freezing of gait across the spectrum of normal, non-freezers, possible freezers and definite freezers.Martina Mancini, Naoya Hasegawa, Daniel S Peterson, Fay B Horak, John G Nutt
Journal of Neurology. 2023-09-01 - 4 citationsEffect of Levodopa and Environmental Setting on Gait and Turning Digital Markers Related to Falls in People with Parkinson's Disease.Vrutangkumar V Shah, James McNames, Patricia Carlson-Kuhta, John G Nutt, Mahmoud El-Gohary
Movement Disorders Clinical Practice. 2023-02-01
Press Mentions
Jeannie’s PD JourneyJuly 17th, 2018- Managing ChangeSeptember 21st, 2009
Grant Support
- Freezing Of Gait: From Clinical Phenomena To Basic Mechanisms Of GAIT And BalanceNational Institute Of Neurological Disorders And Stroke2009–2010
- Levodopa Pharmacokinetics And PharmacodynamicsNational Institute Of Neurological Disorders And Stroke1993–2008
- Methylphenidate In Parkinson'S DiseaseNational Center For Research Resources2005
- Paroxetine In Parkinson'S DiseaseNational Center For Research Resources2004
- Methylphenidate In PDNational Center For Research Resources2004
- DBS , Deep Brain Stimulation And LevodopaNational Center For Research Resources2004
- Levodopa Pharmacokinetics And PharmacodynamicsNational Center For Research Resources1998–2004
- Levodopa Pharmacokinetca And PharmacodynamicsNational Institute Of Neurological Disorders And Stroke2001–2003
- Deep Brain Stimulation &Levodopa--Comparision, Contrasts &InteractionsNational Center For Research Resources2000–2001
- Can Apomorphine Produce A Long Duration ResponseNational Center For Research Resources1998–2001
- Tapping Speed In Normal Subjects--Age And Circadian InfluencesNational Center For Research Resources1997–2001
- Diurnal Patterns Of Motor Performance In Parkinson'S DiseaseNational Center For Research Resources1997–2001
- Pharmacokinetic Interactions Between Remacemide And Levodopa In Patients With PDNational Center For Research Resources1998–1999
- Efficacy Of Dopamine D1 Agonist ABT-431 In PD Patients With Levodopa DyskinesiasNational Center For Research Resources1998–1999
- Safety And Efficacy Of The Dopamine D1 Agonist, ABT-431 In Parkinson'S DiseaseNational Center For Research Resources1997–1999
- GDNF For The Treatment Of Parkinson'S DiseaseNational Center For Research Resources1997–1999
- Monitoring Parkinsonism In Patients With Complex Patterns Of ResponseNational Center For Research Resources1995–1999
- Levodopa Pharmacokinetics And PahrmacodynamicsNational Center For Research Resources1994–1997
- Dose Finding Study With Repeated Doses Of Entacapone In Parkinsons DiseaseNational Center For Research Resources1995
- Dose Finding Study With Repeated Doses Of Entacapone In Parkinson'S DiseaseNational Center For Research Resources1994
- Catecholo-O-Methyltransferase Inhibitor For Treatment Of ParkinsonismNational Center For Research Resources1993–1994
- Deprenyl And Tocopherol Antioxidative Therapy In ParkinsonismNational Center For Research Resources1993
- ON-OFF Phenomenon In Parkinsonism--Importance Of Plasma L-DOPANational Center For Research Resources1985–1993
- Levodopa Pharmacokinetics &PharmacodynamicsNational Institute Of Neurological Disorders And Stroke1987–1992
- Effects Of Amoxicillin On The Response To LevodopaNational Center For Research Resources1991
- Double Blind Crossover Study Of Sustained Release SinemetNational Center For Research Resources1988
- Slow Release Sinemet For The Treatment Of ParkinsonismNational Center For Research Resources1986
- Factors Modifying L-DOPA Transport: Clinical RelevanceNational Institute Of Neurological Disorders And Stroke1985–1986
- Effect Of Clonidine On Spasticity Of Spinal Cord OriginNational Center For Research Resources1985–1986
- Effect Of Anticholinergic Agents On ChoreaNational Center For Research Resources1985–1986
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
